Literature DB >> 11201078

Action monitoring, error detection, and the basal ganglia: an ERP study.

M Falkenstein1, H Hielscher, I Dziobek, P Schwarzenau, J Hoormann, B Sunderman, J Hohnsbein.   

Abstract

The error negativity (Ne or ERN) is an event-related brain potential component, which is assumed to reflect error detection. Recently it has been hypothesized that the basal ganglia are assumed to play a crucial role in error detection. In the present study we ask whether the Ne is altered in patients with Parkinson's disease (PD), who have an impaired function of the basal ganglia. We recorded the Ne in patients and in matched controls, while they performed different tasks that require a relatively high cognitive control, which is supposed to pose particular problems on PD. The Ne was in fact smaller in the patients than in the controls in all tasks. Our results suggest an impairment of error detection in PD for different types of demanding tasks. This supports the hypothesis that the basal ganglia do play an important role for error detection in action monitoring.

Entities:  

Mesh:

Year:  2001        PMID: 11201078     DOI: 10.1097/00001756-200101220-00039

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  57 in total

1.  A computational account of altered error processing in older age: dopamine and the error-related negativity.

Authors:  Sander Nieuwenhuis; K Richard Ridderinkhof; Durk Talsma; Michael G H Coles; Clay B Holroyd; Albert Kok; Maurits W van der Molen
Journal:  Cogn Affect Behav Neurosci       Date:  2002-03       Impact factor: 3.282

2.  Effects of Parkinson's disease on visuomotor adaptation.

Authors:  José L Contreras-Vidal; Ethan R Buch
Journal:  Exp Brain Res       Date:  2003-03-13       Impact factor: 1.972

Review 3.  Learning from experience: event-related potential correlates of reward processing, neural adaptation, and behavioral choice.

Authors:  Matthew M Walsh; John R Anderson
Journal:  Neurosci Biobehav Rev       Date:  2012-06-07       Impact factor: 8.989

4.  Monoaminergic modulation of behavioural and electrophysiological indices of error processing.

Authors:  Jessica J M Barnes; Redmond G O'Connell; L Sanjay Nandam; Angela J Dean; Mark A Bellgrove
Journal:  Psychopharmacology (Berl)       Date:  2013-08-31       Impact factor: 4.530

5.  Executive brain functions after exposure to nocturnal traffic noise: effects of task difficulty and sleep quality.

Authors:  Sergei A Schapkin; Michael Falkenstein; Anke Marks; Barbara Griefahn
Journal:  Eur J Appl Physiol       Date:  2006-01-19       Impact factor: 3.078

6.  Dissociation of response inhibition and performance monitoring in the stop signal task using event-related fMRI.

Authors:  Andre D Chevrier; Michael D Noseworthy; Russell Schachar
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

7.  The relationship between poor sleep and inhibitory functions indicated by event-related potentials.

Authors:  Markus Breimhorst; Michael Falkenstein; Anke Marks; Barbara Griefahn
Journal:  Exp Brain Res       Date:  2008-03-07       Impact factor: 1.972

8.  Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometry.

Authors:  Christian Beste; Carsten Saft; Carsten Konrad; Jürgen Andrich; Anne Habbel; Inga Schepers; Andreas Jansen; Bettina Pfleiderer; Michael Falkenstein
Journal:  Hum Brain Mapp       Date:  2008-02       Impact factor: 5.038

Review 9.  From cognitive neuroscience to geriatric neuropsychology: what do current conceptualizations of the action error handling process mean for older adults?

Authors:  Brianne Magouirk Bettcher; Tania Giovannetti
Journal:  Neuropsychol Rev       Date:  2009-01-27       Impact factor: 7.444

10.  Drug-induced stimulation and suppression of action monitoring in healthy volunteers.

Authors:  Ellen R A de Bruijn; Wouter Hulstijn; Robbert J Verkes; Gé S F Ruigt; Bernard G C Sabbe
Journal:  Psychopharmacology (Berl)       Date:  2004-05-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.